FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology

Go back to FibroBiologics Announces Advances in Burn Treatment Using Proprietary Fibroblast Spheroid Technology
(NASDAQ: FBLG) Delayed: 1.19 +0.05 (4.39%)
Previous Close $1.14    52 Week High
Open $1.17    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.14    EPS
Volume 390,111